Logo Prima Biomed

Welcome to the Newsroom

26 November 2015

Prima BioMed receives Tax Rebate from Australian Government

Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, “the Company”) is pleased to advise that it has received approximately $420k in cash rebate from the Australian federal government's R&D tax incentive program. The cash rebate was provided essentially in respect of expenditure incurred on eligible Australian R&D activities conducted during the 2015 financial year.